Chancery Says Takeda Liable For AbbVie's Lupron Supply Lag
Law 360
SEPTEMBER 22, 2021
Japanese drugmaker Takeda Pharmaceutical Co. for breaching their supply agreement for cancer drug Lupron Depot, a Delaware Chancery judge ruled Wednesday, teeing the companies up for a second trial to determine the damages stemming from ongoing delivery disruptions. is liable to distributor AbbVie Endocrine Inc.
40 
Let's personalize your content